Consensus $4.56. Backs FY24 revenue view up low double-digit to low teens percentage, consensus $50.95B. Sees FY24 core tax rate 18%-22%. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on AZN: AZN Earnings: AstraZeneca Soars on Impressive Q1 Results AstraZeneca put volume heavy and directionally bearish AstraZeneca reports Voydeya approved in EU as PNH add-on treatment AstraZeneca (AZN) Q1 Earnings Cheat Sheet VGK vs. EZU: Which Is the Better European Stock ETF?